Springing between meetings

This time of year always brings a flurry of data across different conferences as we start winding up our AACR coverage, spring forward to the ASCO abstract title drop and prepare for the forthcoming ASGCT meeting.

Of course, much like the weather of late there are always uncertainties involved when looking at abstract titles.

We may know, for example, that certain trials have been announced as positive having met their pre-defined criteria, but as to the exact magnitude of the effect and how much benefit is actually offered in terms of outcomes is another story entirely!

It would be impossible to review all of the meeting in one go, hence we’ll be offering a series of snapshots and discussion highlighting different key topics over the next few weeks.

Here are our notes on the first one in the series…

To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by